Fellow of The National Academy of Public Administration
The scientist’s investigation covers issues in Cancer research, Ovarian cancer, Pathology, Molecular biology and Gene expression. His Cancer research research incorporates elements of Carcinogenesis, Cancer, microRNA and Immunology. His Ovarian cancer study is concerned with the larger field of Internal medicine.
His Pathology study combines topics from a wide range of disciplines, such as Ovarian tumor, Antibody and Ovary. The study incorporates disciplines such as Stratified squamous epithelium, Genetics, Ovarian carcinoma, Vimentin and Differential display in addition to Molecular biology. The various areas that Samuel C. Mok examines in his Gene expression study include Tumor suppressor gene, Endometrium, XIST and Chromatin.
His scientific interests lie mostly in Ovarian cancer, Cancer research, Cancer, Pathology and Internal medicine. Specifically, his work in Ovarian cancer is concerned with the study of Ovarian carcinoma. His research in Cancer research intersects with topics in Immunohistochemistry, Immunology, Cell growth, Ovarian tumor and Metastasis.
His Cancer study incorporates themes from Molecular biology, Immune system and Bioinformatics. Samuel C. Mok combines subjects such as Adenocarcinoma, Loss of heterozygosity and Ovary with his study of Pathology. His Internal medicine research includes themes of Endocrinology, Gene expression and Oncology.
Samuel C. Mok mostly deals with Cancer research, Ovarian cancer, Cancer, Tumor microenvironment and Stromal cell. His research integrates issues of Cell growth, Immune system, Ovarian tumor, Gene silencing and MAPK/ERK pathway in his study of Cancer research. His Immune system study combines topics in areas such as Cytotoxic T cell, Pathology and Mass cytometry.
His Ovarian cancer research is within the category of Internal medicine. His studies in Cancer integrate themes in fields like Proteome, Proteomics, Serous fluid and Clinical trial. His study in Stromal cell is interdisciplinary in nature, drawing from both Cancer cell, Stroma, Immunology and Carcinogenesis.
The scientist’s investigation covers issues in Ovarian cancer, Cancer research, Cancer cell, Cancer and Tumor microenvironment. Samuel C. Mok studies Ovarian cancer, namely Ovarian tumor. His Cancer research research incorporates elements of Cell growth, Interferon, Paclitaxel, Gene silencing and MAPK/ERK pathway.
His Cell growth research integrates issues from Serous fluid, MMP1, Ovary, Carcinoma and Endometrial cancer. His Cancer cell study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dicer, Drosha, and outcomes in patients with ovarian cancer
William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat.
The New England Journal of Medicine (2008)
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin;Hans Henning von Horsten;Yafang Lin;Samuel C. Mok.
Cancer Research (2005)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Toshiyasu Taniguchi;Marc Tischkowitz;Najim Ameziane;Shirley V. Hodgson.
Nature Medicine (2003)
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong.
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.
Chi Lam Au Yeung;Ngai Na Co;Tetsushi Tsuruga;Tsz Lun Yeung.
Nature Communications (2016)
Potential markers that complement expression of CA125 in epithelial ovarian cancer
Daniel G. Rosen;Lin Wang;J. Neeley Atkinson;Yinhua Yu.
Gynecologic Oncology (2005)
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.
Alison J. Quayle;Edith Porter;Aimee A. Nussbaum;Yun Mei Wang.
American Journal of Pathology (1998)
Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry
Bin Ye;Daniel W. Cramer;Steven J. Skates;Steven P. Gygi.
Clinical Cancer Research (2003)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Tomas Bonome;Ji Young Lee;Dong Choon Park;Mike Radonovich.
Cancer Research (2005)
Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology
Samuel C. Mok;Julie Chao;Steven Skates;Kwong Kwok Wong.
Journal of the National Cancer Institute (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: